Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-1,99
KB0,90
PKN65,1165,142,13
Msft420,4420,43-0,24
Nokia3,29053,2965-1,02
IBM191,1191,130,16
Mercedes-Benz Group AG73,8573,870,39
PFE28,0428,050,97
28.03.2024 19:06:59
Indexy online
AD Index online
select
AD Index online
 

  • 28.03.2024 17:35:04
GSK Rg (London)
Poslední obchod Změna (%) Změna (GBP) Objem obchodů (GBP)
17,09 0,20 0,03 103 639 885
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 28.03.2024
Popis společnosti
Obecné informace
Název společnostiGSK plc
TickerGSK
Kmenové akcie:Ordinary Shares
RICGSK.L
ISINGB00BN7SWP63
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 70 212
Akcie v oběhu k 22.03.20244 144 879 946
MěnaGBP
Kontaktní informace
Ulice980 Great West Road
MěstoBRENTFORD
PSČTW8 9GS
ZeměUnited Kingdom
Kontatní osoba 
Funkce kontaktní osoby 
Telefon442 080 475 000
Fax442080477807

Business Summary: GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes more than 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, GSK plc revenues increased 3% to L30.33B. Net income before extraordinary items increased 16% to L4.93B. Revenues reflect US segment increase of 9% to L15.82B. Net income benefited from Commercial Operations segment income increase of 8% to L14.66B, Unallocated segment loss decrease of 31% to L263M. Dividend per share decreased from L0.61 to L0.58.
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
RBSS2004Pharmaceuticals - Diversified
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICSBiological Product (except Diagnostic) Manufacturing
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS2007Biological Product (exc Diagnostic) Mfg
NAICS2007Drugs and Druggists' Sundries Merchant Wholesalers
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
NAICS1997Biological Product (except Diagnostic) Manufacturing
NAICS1997Drug, Drug Proprietaries and Druggists' Sundries Wholesalers
SICPharmaceutical Preparations
SICPharmaceutical Preparations
SICCommercial Physical Research
SICBiological Prod's Not Diagnostic
SICDrugs/proprietaries/sundries



  • Poslední aktualizace: 28.03.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive DirectorEmma Walmsley5401.04.2017
Chief Financial Officer, Executive DirectorJulie Brown6201.05.202303.04.2023
President - Corporate DevelopmentDavid Redfern57
President - Global Supply ChainRegis Simard-01.09.2018
President - Global AffairsPhil Thomson-
Chief Executive Officer, ViiV Healthcare and President - GSK Global HealthDeborah Waterhouse-01.04.2017
Chief People OfficerDiana Conrad-01.01.2009
Senior Vice President, Group General Counsel, Legal and ComplianceJames Ford-01.01.2018
Senior Vice President - Global Communications and CEO OfficeSally Jackson55
Chief Digital and Technology OfficerShobie Ramakrishnan-01.01.2021